Morgan Stanley Maintains Underweight on HCA Healthcare, Lowers Price Target to $380

Benzinga Newsdesk www.benzinga.com Negative 89.0%

Neg 89% Neu 0% Pos 0%

Morgan Stanley analyst Craig Hettenbach maintains HCA Healthcare (NYSE:HCA) with a Underweight and lowers the price target from $425 to $380.